Abstract
Ninety per cent of Canadians have some form of drug plan coverage. However,
staying up-to-date with the policies and requirements of the various
reimbursement schemes is a challenging but necessary requirement for gaining
access to the multi-billion dollar Canadian market. This comprehensive
reference guide is an essential tool for developing and maintaining a clear
understanding of Canadas public and private sector drug plans.
The Canadian Market Access for Pharmaceuticals (C-MAP™ Canadian Drug Benefit
Plans Reference Guide 2006 Edition provides detailed information on the
policies and procedures of the ten provincial prescription drug programs and
includes separate chapters on four federal drug programs. There are also
detailed overviews of the Provincial Cancer Programs, the Patented Medicine
Prices Review Board (PMPRB), the Canadian Coordinating Office for Health
Technology Assessment (CCOHTA), Federal/ Provincial/ Territorial Initiatives
and the private drug plans in Canada. An extensive section on the Common Drug
Review provides a comprehensive description of the CDR process including CDR
rationale for CEDAC decisions, time to decision tracking of submissions and
CDR submission forms and templates available online. The executive summary
provides essential facts on each of the drug plans in convenient tabular
format.
This publication includes, but is not restricted to:
- Identification of each provincial plan or selected federal program
- Detailed description of each plan
- Identification of the governing acts and regulations
- Drug plan expenditures and use profile
- Formulary descriptions
- Summaries of processes and procedures for listing and approval
- Special authorization processes
- Reimbursement regulations and procedures
- Requirements for manufacturers submissions to the Common Drug Review and
directly to the provincial drug plans including generic products
- A description of the Special Drug Programs for each province
- Reporting structure within each province
- PDCI online version of C-MAP™Canadian Drug Benefit Plans Reference Guide
- A glossary of terms
The new features of the 2006 Edition are:
- A Comprehensive Section on Provincial Cancer Programs
- A Listing Process Summary Table for Interchangeables including generic
submission deadline dates (where applicable)
- An improved and more comprehensible section on submission requirements for
CDR and non-CDR submissions
- An enhanced Private Payers Section
- A free trial of PDCIs Canadian Drug Claims Database
View Cart
